In this review, the authors examine the latest evidence on the roles of gland atrophy and ductal hyperkeratinization in the development of meibomian gland dysfunction.

A team led by Mount Sinai researchers has identified stem cell populations and mechanisms underlying age-related degeneration in glands that are vital to eye function.

Dr. Cornelia Peterson is dedicated to finding treatments for cancer by researching tumors that develop in Meibomian glands, the specialized oil-secreting glands of the eyelid. She joined Cummings ...

A chalazion can develop when a meibomian gland at the edge of an eyelid becomes blocked or inflamed. These glands produce oil that lubricates the surface of the eye.

Tarsus is also developing TP-03 as an investigational therapy for the treatment of Meibomian Gland Disease, which is currently being studied in a Phase 2a clinical trial.

Meibomian gland dysfunction (MGD) is a common eye condition, yet many people don't realize they have it. You get it when there's a problem with a few dozen tiny glands in your eyelids that help ...

Despite the prevalence of dry eye disease and meibomian gland dysfunction, it remains a mystery as to what exactly causes this condition and how we can address it effectively. However, recent ...

Meibomian gland dysfunction (MGD) is underdiagnosed and undertreated, with asymptomatic disease far more common than symptomatic disease. As the condition progresses, patients who were initially ...

A short course of azithromycin matched a standard doxycycline regimen for relief of severe meibomian gland dysfunction (MGD) and caused fewer adverse events (AEs), a randomized trial showed. After ...

A systematic review found that there were currently a limited number of clinical trials evaluating treatment for dry eye disease (DED) that is associated with meibomian gland dysfunction (MGD).